PM360

OCTOBER 13, 2023

Of the eight FDA-approved weight loss drugs on the market, these two are making waves for doctors who believe they represent “a new era for weight loss medications,” and “changing options and giving hope.” They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP).

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

Pharma Leaders

MAY 18, 2023

The US Food and Drug Administration (FDA) has accepted Ardelyx’s resubmitted New Drug Application (NDA) for XPHOZAH (tenapanor) to control serum phosphate in adult patients with chronic kidney disease on dialysis who have had an insufficient response or intolerance to a phosphate binder therapy.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Prospecting 52

pharmaphorum

JULY 18, 2022

The Dutch biotech submitted the ADC to the FDA last week and said this morning the EMA had formally started its review of the drug for HER2-positive, locally advanced or metastatic breast cancer that can’t be treated with surgery. The post Byondis cues up US, EU decisions on breast cancer ADC in 2023 appeared first on.

Side effects 57

Side effects Physicians FDA Marketing 57

pharmaphorum

SEPTEMBER 16, 2022

Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects. However, side effects do happen. Regarding both common cold and headache, they are as well among the side effects reported for similar drugs.

Management 78

Management Side effects Patients Safety 78

PM360

AUGUST 9, 2022

Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension. CareTrack Health.

Prescription 105

Prescription Medical Side effects Patients 105

Medgadget

FEBRUARY 17, 2023

Currently, the awkwardness of conventional laparoscopic tools keeps many physicians from using them in a variety of cases. Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. are still done in an open fashion.

Physicians 80

Physicians Engineering Side effects Leads 80

European Pharmaceutical Review

DECEMBER 27, 2023

5 Subsequently, transplant centres administering CAR T cells in various pharma-sponsored clinical trials had to establish multi-disciplinary teams, including not just haematologists and oncologists but also intensive-care physicians and nurses, nephrologists, neurologists, pharmacists and others. FDA; 2022 [cited 2023 Mar].

Manufacturing 83

Manufacturing Food and Drug Administration Patients Pharma 83